Using Placebos in Research Involving Terminal Illnesses
Mark Day and Ryan Hicks
Abstract
Placebos are medical interventions that falsely lead
patients to believe that they are receiving treatment and
that their condition is being changed, when truly no
specific treatment is being administered. Using
placebos in research involving terminal illnesses has
become debatable. While a placebo could potentially
give way to new treatments, through testing alongside a
specific drug in a clinical trial, the placebo itself may
fail and the patient is not cured leading to possible
fatality. It has been found that using placebos in
research, like performing surgeries, can aid in medical
or clinical research and could help our society
financially by discouraging unnecessary operations. On
the other hand, there are also risks involved, including
the health risks that may result from the placebocontrolled trial, and most importantly the justification
and ethics of using placebos on patients without their
consent. While evaluating several studies involving
placebo-induced treatments, we have discovered
methods in which placebos can help society; although
these helpful means can also raise issues regarding
one’s ethics. Using placebos in treatments will not
necessarily treat the illness itself, but they can be
beneficial towards research in discovering new
treatments for terminal illnesses.

Discussion
Placebos have helped patients make full recoveries from
their terminal illness on their own until the patients are told
that the treatment they received is not the drug they were
told that they were receiving. In one particular case the
treatment failed and the patient had a relapse after reading
an article about the ineffective drug, and the patient became
more sick than before the treatment had taken place. This
particular case involved the trial-stage cancer drug called
Krebiozen. Krebiozen was a drug that was supposed to be
the end to cancer, but this was not the case. The drug never
got approved and instead was less effective than the placebo
given in the double blind trial (The Placebo Effect). The
reason that the Krebiozen placebo helped the patient get
better was because of the mental effect that taking a drug to
cure them was working and their mind telling their body
that this will help it so it did, though it only worked because
the patient believed it would. This shows how the mind can
effect the body in more ways then one. The placebo itself
can be used to help the human but at the same time it can
hurt since placebos fool the mind into thinking that the body
is receiving treatment and the patient will feel fine but in
truth the body isn’t fine at all. The placebo is just tricking
the brain into easing the pain naturally so that the patient
won’t feel it and think that they are cured.
Another point is that Placebo-controlled trials can hinder
the research and treatment of terminal illnesses. For
Ethical Question
example, one article claims that the rigorous drug trials
Is it ethical to use placebos in research involving
administered by the Food and Drug Administration deny
terminal illnesses? Is it ethical to use placebos on
patients with cancer from getting access to potentially
patients who believe that they are really being treated for lifesaving drugs. One of the ways the FDA prohibits cancer
their illness?
patients from receiving potential life-saving vaccines, is
through the increasing requirement for companies to hold
Introduction
randomized and placebo-controlled trials with new cancer
The use of placebos in research involving terminal
treatments. The potential health risks and mainly the ethics
illnesses is debatable. There are possible benefits to
of using placebos on patients makes placebo research
performing placebo-controlled trials. However, the
debatable (FDA Rules Hinder Cancer Vaccines).
ethics of using placebos on patients without their
consent is what drives our ethical question.
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Analysis
The two topics that have been discussed here
illustrate the ethics of Placebo research in
terminal illnesses. In The Placebo Effect the
patient had a full recovery from being told that
the medicine given to them would help them
fully recover. This can be ethical in some ways
but it mostly isn’t ethical at all because telling
the patient that the placebo will help them get
better is false because it truly has no actual
medical effects. Their condition goes back to the
way it was and will eventually lead to death.
The other topic demonstrates how having a
placebo can hinder the treatment of terminal
illness which in turn can hurt the patient even
more than it already has and the patient can no
longer be helped and will be forced to wait for
the inevitable untreated because of specific
guidelines that must be followed.

Conclusion
The use of placebos is mainly just a way
of psychological treatment. Placebo
treatment does not treat the illness itself.
Performing placebo-controlled trials on
patients is unethical if they are not
informed and have not given their
consent. Even if the patient is terminally
ill, they should have the right to know
exactly how they are being treated.
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